- Home
- / Chi Sheng Pharma & Biotech
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Chi Sheng Pharma & Biotech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
NT$26.3
2024-10-29
Market Capitalization
NT$1.5 B
2024-10-29
Revenue
NT$1.4 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| TWD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 967.4M | 1.0B | 979.4M | 1.0B | 1.1B | 1.1B | 1.2B | 1.4B |
| Cost of goods sold | 599.7M | 601.4M | 573.4M | 617.3M | 659.2M | 657.1M | 703.1M | 795.0M |
| Gross profit | 376.8M | 432.3M | 415.5M | 435.2M | 492.4M | 416.6M | 475.5M | 595.2M |
| Gross profit margin, % | 42.3% | 42.4% | 41.8% | 43.1% | 39.3% | 40.8% | 43.2% | |
| Operating expense total | 251.2M | 253.0M | 247.4M | 255.1M | 268.7M | 281.9M | 298.2M | 309.7M |
| Depreciation and amortization | 73.8M | 81.4M | 83.0M | 77.7M | 61.4M | 60.7M | 65.1M | 72.4M |
| EBITDA | 125.6M | 179.3M | 168.1M | 180.1M | 223.8M | 134.7M | 177.3M | 285.5M |
| EBITDA margin, % | 17.5% | 17.2% | 17.3% | 19.6% | 12.7% | 15.2% | 20.7% | |
| EBIT | 50.7M | 96.8M | 82.9M | 106.8M | 161.1M | 72.6M | 107.8M | 200.5M |
| EBIT margin, % | 9.5% | 8.5% | 10.2% | 14.1% | 6.8% | 9.2% | 14.6% | |
| Interest income | 2.0M | 1.3M | 1.7M | 978.0K | 1.4M | 14.5M | 14.5M | 8.4M |
| Interest expense | 411.0K | 263.0K | 162.0K | 1.1M | 1.5M | 1.5M | 1.7M | 517.0K |
| Pre tax profit | 60.1M | 97.3M | 81.4M | 104.8M | 162.3M | 87.3M | 137.7M | 206.8M |
| Income tax expense | 17.8M | 24.8M | 22.3M | 24.1M | (17.0M) | 18.7M | 27.1M | 42.5M |
| Net Income | 42.3M | 72.5M | 59.1M | 80.8M | 179.3M | 68.7M | 110.6M | 164.3M |